Cancer Diagnostics – News and Features
News
NCI Funds New Nanotechnology Center at Stanford
The mission of the NCI Centers of Cancer Nanotechnology Excellence is to integrate nanotechnology into cancer research.
News
Orion Genomics, University of Glasgow Collaborate to Identify Cancer Biomarkers
Scientists at Orion and the University of Glasgow will use Orion's methylation technologies to identify biomarkers.
News
Clinical Data Announces Collaborative Research Agreement with UPCI
Clinical Data will apply metabolomics analysis to serum samples from a population of patients diagnosed with lung cancer.
News
Immunicon Enters into License Agreement with Kreatech
The agreement enables Immunicon to use ULS technology in conjunction with Immunicon's technologies.
News
CytoGenix Announces Completion of synDNA™ Production Module Prototype
The device was designed for the commercial production of cell-free DNA.
News
Patient Outcomes Linked to Biomarker Levels by Quantitative Technology
AQUA has proven to be an effective tool in determining the flaws and inconsistencies associated with immunohistochemistry.
News
Clarient Inc. and Health Discovery Corporation Jointly Announce Licensing Agreement
Clarient licenses HDC's Support Vector Machine patent portfolio in the field of peripheral rare cell detection.
News
IBM Joins Forces with top Cancer Centers
IBM Collaborates with MSKCC, the Molecular Profiling Institute and Sainte-Justine Research Center.
News
Genesis Bioventures Announces Restructuring Management Agreement
Genesis Bioventures has retained Experigen Management Company to lead its reorganization and restructuring.
News
Acrongenomics Retains KGMC Group
KGMC Group will work with Acrongenomics to complete formal validations of the advanced Nano-JETA™ platform.
Advertisement
